U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721961) titled 'A Study of MI078 for Postpartum Depression' on July 10.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled trial consisting of an experimental drug group and a placebo group, each enrolling 100 participants. The objective of this study is to assess the efficacy and safety of MI078 capsules for the treatment of postpartum depression.
Study Start Date: July 10
Study Type: INTERVENTIONAL
Condition:
Postpartum Depression (PPD)
Intervention:
DRUG: MI078 capsule
MI078 capsule for 3 days
DRUG: Placebo of MI078 capsules
Placebo for 3days
Recruitment Status: RECRUITING
Sponsor: Nanjing Minova Pharma...